Innovative. Qualified. Connected.

New therapeutic options for chronic inflammatory diseases

Head: PD Dr. med. Arnd Kleyer

Controlled clinical trials are necessary to assess the efficacy and safety of drugs in rheumatic diseases. In the Clinical Trials Unit of the Department of Medicine 3, under the direction of PD Dr. med. Arnd Kleyer, Phase 1-4 studies are offered and carried out for various rheumatic diseases.

The main focus is on the clinical pictures: Rheumatoid arthritis, psoriatic arthritis, spondylarthritides (axial spondyloarthritis), vasculitides (especially large-vessel vasculitides) and collagenoses (systemic lupus, dermatomyositis or systemic scleroderma).

In addition to participation in multicenter studies, the strength and expertise lies in conducting our own studies, which are performed according to the German Drug Law (IITs according to AMG). This is done in close cooperation with the sponsors of study projects and in collaboration with the Center for Clinical Studies (CCS) of the Universitätsklinikum Erlangen in order to fulfill the legal and ethical requirements.

The Clinical Trials Unit has the spatial and personnel requirements for this, with direct connection to the entire care structure of the Universitätsklinikum. This integration, as well as the special training and many years of experience of our staff, guarantee the highest quality standards.